The growing healthcare market also offers great opportunities in the future. Our Flensburg subsidiary Queisser Pharma with its strong brands such as Doppelherz and Protefix sells products for self-medication worldwide. The foreign share of business is growing and is now at 36%.
Queisser Pharma is a reflection of the HGDF idea: Visionary management, continuous growth, high quality standards, environmental awareness, and strong positioning with its own brands in a growth environment – all of this makes Queisser Pharma an investment that has been an excellent match for HGDF for decades.
Multiple award-winning employer
The story of today's successful Flensburg company begins in Hamburg in 1897 with the pharmacist Alfred Queisser, who manufactured health and care products such as creams, liquid soap, and toothpaste. With 585 employees, Queisser Pharma is one of the largest employers on the Flensburg Fjord today and sells a variety of dietary supplements, medical products, over-the-counter medicines, and cosmetics in many regions of the world.
Today, Queisser is the market leader in numerous segments. The subsidiaries in Russia, Ukraine, Romania, Bulgaria, Turkey, and Poland also contribute to the positive development. Queisser products are usually sold in pharmacies, drug stores, and food retailers. In addition to the European markets, Queisser is also active in the booming markets in the Middle East, Africa and Asia, and in China in particular.
Doppelherz is the company's best-known brand. Developed in 1917, the Doppelherz range includes over 240 preparations in 14 areas of application.
Trust and appreciation, always courageous decision-making, and constant readiness to change shape our corporate culture.
The Chinese love Doppelherz
Doppelherz has been experiencing a sales boom in China since around 2015, especially among young consumers. Manuel Neuer and the Chinese actress Qin Lan acted as brand ambassadors. In addition to Doppelherz and Protefix, Queisser also stands for brands such as Stozzon, Litozin, and Tiger Balm.
Lots of ambition when it comes to environmental protection
Queisser Pharma wants to produce even more environmentally friendly in the future. The company is already fully offsetting CO₂ emissions through financial support for climate protection projects. By switching from plastic to recycled cardboard for displays, the pharmaceutical manufacturer was recently able to save 18 tons of plastic waste. Packaging in plastic blisters has also been switched to cardboard boxes. In this way, another 600 kilograms of plastic per year can be avoided.